Cardiac Versus Renal Response to Volume Expansion in Preclinical Systolic Dysfunction With PDEV Inhibition and BNP

Overview of attention for article published in JACC: Basic to Translational Science, December 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

So far, Altmetric has seen 31 X posts from 31 X users, with an upper bound of 446,636 followers.

Cardiac Versus Renal Response to Volume Expansion in Preclinical Systolic Dysfunction With PDEV Inhibition & BNP, @MayoClinicCV et al, @JACCJournals https://t.co/TBMEK8pbxH #bloodvolume #cardiac #systolicdysfunction #renaldysfunction #fluidregulation

RT @JACCJournals: Can the administration of phosphodiesterase-V inhibition (PDE5i) and B-type natriuretic peptide (BNP) enhance cardiorenal…

RT @JACCJournals: Can the administration of phosphodiesterase-V inhibition (PDE5i) and B-type natriuretic peptide (BNP) enhance cardiorenal…

RT @JACCJournals: Can the administration of phosphodiesterase-V inhibition (PDE5i) and B-type natriuretic peptide (BNP) enhance cardiorenal…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 27 additional X posts.